Pure Bioscience Inc. | Cash Flow
Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
7,671.00
11,050.00
7,627.00
14,371.00
6,263.00
7,442
Depreciation, Depletion & Amortization
311.00
248.00
206.00
219.00
276.00
285
Other Funds
2,216.00
4,547.00
2,492.00
9,523.00
1,541.00
3,061
Funds from Operations
5,144.00
6,255.00
4,929.00
4,629.00
4,446.00
4,096
Changes in Working Capital
1,240.00
71.00
1,059.00
362.00
116.00
209
Net Operating Cash Flow
3,904.00
6,326.00
5,988.00
4,991.00
4,562.00
3,887
Capital Expenditures
231.00
112.00
107.00
405.00
226.00
Sale of Fixed Assets & Businesses
-
66.00
-
-
-
Net Investing Cash Flow
231.00
46.00
107.00
405.00
226.00
Issuance/Reduction of Debt, Net
1,376.00
528.00
-
-
-
Net Financing Cash Flow
3,290.00
6,426.00
7,405.00
9,269.00
1,234.00
Net Change in Cash
845.00
54.00
1,310.00
3,873.00
3,554.00
Free Cash Flow
3,916.00
6,347.00
6,069.00
5,381.00
4,768.00
Change in Capital Stock
4,666.00
6,954.00
7,405.00
9,269.00
1,234.00
About Pure Bioscience
View Profile
